Adsilico
The company provides in silico trial services using generative AI to create customizable virtual models of human anatomy, physiology, and pathology. These digital representations allow medical device manufacturers to assess safety and performance in diverse virtual patient populations before proceeding to human clinical tests. The platform aims to identify design failures early, reduce research and development costs, and accelerate the time to market for implantable medical devices.
Visit websiteLeeds, UK
Healthtech
Medical Devices
Generative AI
Software as a Service
Funding summary
- Total raised
- €4.1M
- Funding rounds
- 1
Investors in Adsilico
Investors on record for Adsilico. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Adsilico?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors